Reach Us +1-947-333-4405
Editor - Nabil Mohie Abdel-Hamid | Kafrelsheikh University | 25895
ISSN: 2157-2518

Journal of Carcinogenesis & Mutagenesis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Nabil Mohie Abdel-Hamid

Nabil Mohie Abdel-Hamid
Nabil Mohie Abdel-Hamid
Prof of Cancer Biology (Biochemistry Department)
Ex-Dean of Pharmacy College
Kafrelsheikh University
Kafrelsheikh University


Professor of Cancer Biology at Department of Biochemistry, Ex- and First Dean and Founder of Faculty of Pharmacy, Kafrelsheikh University, Egypt. Had his Master in Biochemistry by 1989, and his PhD in biochemistry by 1999. Member of The Higher Consulting Organization of Egyptian Scientists Council. Deputy of Director of: The Egyptian Association of Cancer Research. Member in: The Arab Evaluators for Scientific Degree Promotions for Professorships. Member in: The Egyptian Evaluators for Scientific Degree Promotions for both associate and full Professorships.

Research Interest

Cancer Biology, Principal Instructor and interested in Hepatocellular Carcinoma Research(Both Early Detection, Looking for New Sensitive and Specific Markers and Therapeutic Perusal), as New Trends in Management of Hepatocellular Carcinoma, Including Chemo and Radio Sensitization to Cancer Therapy. After long time of studying cell membrane, we now work on targeting liver cancer cell through membrane protein leads to minimize side effects, dose burdens, and treatment durations, with a maximal efficacy. Published 62 international manuscript, 2 international books (USA and UK), 5 National books, presented more than 150 TV meetings in awareness of herbal , medical and pharmaceutical fields.